MoneyWorks4Me

Divi’s Laboratories informs about conference call

20 May 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Divi’s Laboratories has informed that it enclosed the schedule of earnings conference call for the 4th quarter and year ended March 31, 2024 to be held on May 25, 2024 at 14:30 hrs (IST).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..